The largest automakers in the world by market cap
As highlighted by Oktay Kavrak, CFA, the largest US firm is only number 10. There is also an interesting (still relatively unknown) newcomer: VINFAST, a car brand from Vietnam. The stock is up nearly 700% since going public on the Nasdaq and - at least briefly - became the 3rd biggest automaker in the world and at one point was worth more than Boeing, Disney and Goldman Sachs. What is also notable is that VINFAST is not profitable yet. Moreover, the number of cars is still pretty low: 24,000 in 2022 (vs. millions for the more traditional automakers or Tesla). Source Chart: Leverage Shares
This chart from Morgan Stanley shows that growth stocks are missing in Europe. That's why European indices are trading like value stocks
Source: Morgan Stanley, HolgerZ
After the outstanding Nvidia figures and outlook, analysts have raised the avg price target for the chip giant from $520 to $620
Source: HolgerZ, Bloomberg
The median year since 1928 has experienced a 13% intra-year drawdown in the S&P 500, making 2023 relatively mild by comparison
The 7.8% pullback in February-March is the largest thus far. Soruce: Charlie Bilello
If Nvidia continues like this, the chip company will soon be as big as all 40 Dax comps combined
Source: Bloomberg, HolgerZ
$NVDA soars ~10% after hours, crushing sky-high expectations “A new computing era has begun" - Co-founder & CEO, Jensen Huang
Still, let's keep in mind that part of the buzz is already baked in the valuation as illustrated below Source: Quartr
Warren Buffett's Berkshire Hathaway reported $1 trillion of assets for the first time last quarter
That's roughly triple the assets of Apple, 10 times Tesla's figure, and 20 times Nvidia's total. Berkshire's assets have ballooned 33,000-fold under Buffett, from under $30 million when he started. Source: business insider
Eli Lilly stock hit a new record high yesterday as the company continues to record a surge in sales for its buzzy diabetes drug Mounjaro
Sales of Mounjaro, which has also gained popularity for weight loss, came in at $979.7 million for the second quarter, up from $16 million a year earlier when it was introduced (2Q results were publichsed 2 weeks ago). That helped the drug company post higher-than-expected sales for the second quarter. Novo Nordisk is also surfing on the strong demand for a similar weight loss blockbuster
